You just read:

Blueprint Medicines to Present Preliminary Data from Ongoing Phase 1 Clinical Trial for BLU-285 in Advanced Systemic Mastocytosis at 2016 ASH Annual Meeting

News provided by

Blueprint Medicines Corporation

Nov 03, 2016, 09:01 ET